Photosensitivity Disorders
Welcome,         Profile    Billing    Logout  
 3 Companies   3 Products   3 Products   13 Mechanisms of Action   0 Trials   14 News 
  • ||||||||||  Enrollment closed, Trial primary completion date:  The Head Injury-associated Photosensitivity and Pupillary Function (HIPP) Study (clinicaltrials.gov) -  Oct 23, 2014   
    P=N/A,  N=80, Active, not recruiting, 
    Active, not recruiting --> Completed | N=80 --> 40 Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2014 --> Dec 2014
  • ||||||||||  lenalidomide / Generic mfg.
    Enrollment change, Trial termination, Trial primary completion date:  LENAKAP: Lenalidomide in Kaposi Disease Associated With HIV Infection (clinicaltrials.gov) -  Aug 1, 2014   
    P2,  N=12, Terminated, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2014 --> Dec 2014 N=35 --> 12 | Active, not recruiting --> Terminated | Trial primary completion date: Oct 2013 --> Feb 2014
  • ||||||||||  Trial completion:  Skin Aging in Renal Transplant Patients (clinicaltrials.gov) -  Feb 19, 2014   
    P4,  N=100, Completed, 
    N=20 --> 0 Enrolling by invitation --> Completed
  • ||||||||||  Trial completion:  The Sun Protective Effect of Melatonin (clinicaltrials.gov) -  Aug 27, 2013   
    P1,  N=22, Completed, 
    Not yet recruiting --> Recruiting Recruiting --> Completed
  • ||||||||||  lenalidomide / Generic mfg.
    Enrollment closed:  LENAKAP: Lenalidomide in Kaposi Disease Associated With HIV Infection (clinicaltrials.gov) -  Jul 16, 2013   
    P2,  N=35, Active, not recruiting, 
    Recruiting --> Completed Recruiting --> Active, not recruiting
  • ||||||||||  lenalidomide / Generic mfg.
    Trial initiation date:  LENAKAP: Lenalidomide in Kaposi Disease Associated With HIV Infection (clinicaltrials.gov) -  Dec 8, 2011   
    P2,  N=35, Active, not recruiting, 
    Initiation date: Jul 2012 --> May 2013 Initiation date: Jul 2011 --> Oct 2011